Nexilis AG provides support for the successful commercialisation of new medical technology inventions and products in the overlapping field between medical devices and biotechnology. Nexilis AG has experience in establishing product development processes considering quality and regulatory aspects. Nexilis AG has an established process and clinical networks for defining and managing appropriate development programmes. These result in regulatory filing, managed clinical studies and market entry. Experienced associates provide specialised intellectual property and regulatory services.
We can provide all or part of the complete technology transfer process including.
- Strategic Planning
- Business Development
- Product Development
Based on our experience and clinical networks, as well as good knowledge of small company issues, we provide focused support in medical and biomedical device technology transfer. Expertise in the international medical device industry, quality management and regulatory affairs makes Nexilis AG the ideal partner for the medical device, pharmaceutical and biotechnology industry.
Nexilis primary focus, however, is to co-develop products using its proprietary technology through phase I or II clinical trials. Nexilis coordinates and performs the research, preclinical, and clinical activities and partners for later stage clinical trials.
|
